Rada J A, Carlson E C
Pittsburgh Eye and Ear Institute, Pennsylvania 15213.
Anat Rec. 1991 Sep;231(1):35-47. doi: 10.1002/ar.1092310106.
Renal glomerular basement membranes (GBMs) exhibit a charge-selective barrier, consisting of heparan sulfate proteoglycan (HSPG) that restricts the passage of anionic molecules into the urine. Previous efforts to localize the HSPG core protein within various layers of the GBM have been contradictory. Furthermore, attempts to correlate proteinuria in several disease states with a decrease in anionic sites of HSPG core protein have yielded conflicting results. When antibodies to HSPG from the EHS tumor matrix [anti-(EHS) HSPG] and GBMs [anti-(GBM) HSPG] were used together with immunogold to label renal tissues from puromycin aminonucleoside nephrotic (PAN) rats, immunolabeling results indicated that a portion of the protein core recognized by anti-(EHS) HSPG was significantly reduced, while immunolabeling with anti-(GBM) HSPG was only slightly reduced in early PAN. Anionic sites (stained with the cationic probe, polyethyleneimine) within the lamina rara externa of the GBM remained unaltered throughout the course of PAN.
肾小球基底膜(GBM)呈现出电荷选择性屏障,由硫酸乙酰肝素蛋白聚糖(HSPG)组成,可限制阴离子分子进入尿液。先前将HSPG核心蛋白定位在GBM各层内的研究结果相互矛盾。此外,将几种疾病状态下的蛋白尿与HSPG核心蛋白阴离子位点减少相关联的尝试也产生了相互矛盾的结果。当将来自EHS肿瘤基质的HSPG抗体[抗 - (EHS)HSPG]和GBM抗体[抗 - (GBM)HSPG]与免疫金一起用于标记嘌呤霉素氨基核苷肾病(PAN)大鼠的肾组织时,免疫标记结果表明,抗 - (EHS)HSPG识别的部分蛋白核心显著减少,而在早期PAN中,抗 - (GBM)HSPG的免疫标记仅略有减少。GBM外疏松层内的阴离子位点(用阳离子探针聚乙烯亚胺染色)在PAN病程中保持不变。